Navigation Links
STRYKER Signs Definitive Agreement to Acquire CONCENTRIC MEDICAL, Inc.
Date:8/31/2011

MOUNTAIN VIEW, Calif., Aug. 31, 2011 /PRNewswire/ -- Concentric Medical, Inc., a global leader in acute ischemic stroke intervention, today announced that Stryker Corporation (NYSE: SYK) has signed a definitive agreement to acquire Concentric Medical for $135 million in an all-cash transaction. The acquisition, pending customary regulatory approvals, is expected to close early in the fourth quarter of 2011.

The acquisition of Concentric Medical provides Stryker with immediate entry into the fastest growing and most innovative segment of the interventional neurovascular space. Ischemic stroke represents the vast majority of all strokes, and this strategic acquisition offers Stryker immediate access into the rapidly expanding Acute Ischemic Stroke segment with a proven technology leader.

Concentric Medical manufactures and markets minimally invasive devices that are endovascularly delivered to the brain to remove blood clots that cause ischemic stroke. Concentric was a pioneer in the development of acute ischemic stroke treatments with the launch of the first Merci® Retriever in 2004. Most recently, the company successfully launched the Trevo™ Retriever in Europe in 2010. The Trevo Retriever is the first device utilizing Stentriever™ technology, a novel approach to retrieving clots from the neurovasculature. The Trevo Retriever is currently being evaluated in the TREVO 2 Trial, a pivotal clinical trial investigating the safety and efficacy of the Trevo Retriever.

“We believe Stryker is the ideal strategic partner for Concentric and combining Concentric with Stryker’s Neurovascular division will provide opportunities to accelerate the development of technology and clinical evidence and will allow the commercial expansion of Concentric’s ischemic stroke therapy globally. Our team is excited to be joining the Stryker organization,
'/>"/>

SOURCE Concentric Medical
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Stryker Orthopaedics Enters into Agreement with OrthoSensor for Intelligent Surgical Platform
2. Landmark Stryker Trial Establishes Coiling as Safe and Effective Treatment for Ruptured and Unruptured Aneurysms
3. Stryker Ends Distribution Agreement With Corin PLC
4. Stryker Announces Exclusive Collaboration With RegenLab
5. Stryker Launches VersiTomic G-Lok™
6. Stryker Orthopaedics Launches Its First iPad™ Apps for Surgeons, Available Through Apples App Store(SM)
7. Stryker Features Tissue-Preservation Hip Arthroscopy Platform, Sponsors Surgeon Education Events at the AAOS Annual Meeting
8. Fred Funk Becomes Spokesperson for Stryker Orthopaedics
9. Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System
10. Stryker Declares a $0.18 Per Share Quarterly Dividend
11. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 China Biologic Products, Inc. ... fully integrated plasma-based biopharmaceutical company in China ... learned from a public announcement issued by Shanghai RAAS ... listed on Shenzhen Stock Exchange, that on May 21, ... ("Ms. Chan"), one of the shareholders of the Company, ...
(Date:5/24/2013)... , May 24, 2013 In accordance with Rule ... Rule 14e-1 of the United States Exchange Act, Echo Pharma ... offer for Elan Corporation (NYSE: ELN). Background ... Pharma") made an offer for the entire of the issued ... ("Elan") (the "Original Offer").  On 20 May ...
(Date:5/24/2013)... -- The potential of the pulmonary route ... agents has been receiving undeniable attention with the recent ... The crucial formulation considerations for orally inhaled products together ... role in the efficiency of pulmonary delivery, and great ... formulation techniques and devices in recent years. ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2
... Mass. and SYDNEY, April 15, 2011 HeartWare ... HIN), a leading innovator of less invasive, miniaturized ... of advanced heart failure, today announced the presentation ... heart transplantation (BTT) study, ADVANCE, showing 180-day survival, ...
... Nanotechnologies, Inc. ("Shrink") (OTCBB:INKN), an innovative high technology ... Shrink,s Cell Align™ cell culturing and tissue engineering ... substrate has been filed with the US Patent ... a micro-fabricated substrate with non-periodic (or random) linear ...
Cached Medicine Technology:HeartWare Reports Additional Data from Bridge-to-Transplant Clinical Trial and Continued Access Patients 2HeartWare Reports Additional Data from Bridge-to-Transplant Clinical Trial and Continued Access Patients 3HeartWare Reports Additional Data from Bridge-to-Transplant Clinical Trial and Continued Access Patients 4HeartWare Reports Additional Data from Bridge-to-Transplant Clinical Trial and Continued Access Patients 5Shrink Nanotechnologies Announces That Critical Cell Align Tissue Engineering Platform Patent as Well as IP on a Novel Immunoassay Substrate Material Has Been Filed With the USPTO 2Shrink Nanotechnologies Announces That Critical Cell Align Tissue Engineering Platform Patent as Well as IP on a Novel Immunoassay Substrate Material Has Been Filed With the USPTO 3
(Date:5/24/2013)... Los Angeles, CA (PRWEB) May 24, 2013 ... “Looking Good on Facebook: Social Media Leads to Spikes in ... indicate that there is a growing prevalence of facial ... utilize social media. These people have become keenly aware of ... profiles on sites such as Facebook, Google and even Skype's ...
(Date:5/24/2013)... FRIDAY, May 24 (HealthDay News) -- The number ... units after spending time in an emergency room ... new research. The study, conducted by researchers ... Health and Health Services in Washington, D.C., found ... room on average before being admitted to the ...
(Date:5/24/2013)... fractional flow reserve (FFR) using pressure wire assessment ... leads to significant changes in the management of ... a study reported at EuroPCR 2013. , The ... strategy at coronary angiography for diagnosis of chest ... assessment of FFR in all the main coronary ...
(Date:5/24/2013)... Ore. A new discovery at Oregon Health & ... body effectively reacts when infected with the highly evasive ... researchers has been utilizing this unique approach to develop ... shown promising results in animal studies. This latest research ... edition of the journal Science . , ...
(Date:5/24/2013)... CBT News.com recently announced the addition of Tom Gonter as ... news organization with 12 years experience in online and social ... that’s so forward-thinking in their approach,” says Gonter. “CBT News ... on the rise.” , Atlanta born and raised, Gonter began ... at Cycle News and Boating World. He made the move ...
Breaking Medicine News(10 mins):Health News:Facebook and Google – Is Social Media Driving Demand for Plastic Surgery? 2Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:OHSU research highlights promising strategy to help vaccines outsmart HIV 2
... , ... , an Australian start-up, has been selected to showcase its revolutionary service for managing ... ... Global financial innovation conference, Finovate, has selected Controlabill to showcase its revolutionary service for ...
... ... accreditation by COLA, a national healthcare accreditation organization. , ... (PRWEB) March 24, 2010 -- This year, US ... performance in quality patient testing and overall exemplary application of the principles of laboratory ...
... The ... But, what most of us don’t know is that chemotherapy wreaks havoc on our teeth ... with your dental health while undergoing chemotherapy and radiation. , ... (PRWEB) March 24, 2010 -- Steven McConnell - a Marin ...
... , ... will be presenting three sessions in April to increase awareness in the U.S. about the ... can increase early detection and prevention. , ... New York, NY (Vocus) March 24, 2010 -- The Bella Moss Foundation, a ...
... , ... Many of seniors, greatest fears are tied to the loss ... to remain active because of conditions that often accompany aging. But staying ... Paul Hogan. In response to mounting research that underscores the mental and ...
... ... ... -- At just over 18 pounds and with a sound level of only 58 dBA, ... quieter than its battery-operated competitors. Powered by a lithium ion battery with 30 minutes of ...
Cached Medicine News:Health News:Global Financial Innovations Conference Chooses Australian Start Up, Controlabill 2Health News:US Wellness, Inc. Receives National Recognition for Laboratory Excellence 2Health News:Recommended Dental Care for Chemotherapy Patients -- Advice from Steven McConnell, DDS 2Health News:Recommended Dental Care for Chemotherapy Patients -- Advice from Steven McConnell, DDS 3Health News:The Bella Moss Foundation Announces U.S. Tour to Raise Awareness of MRSA in Pets 2Health News:The Bella Moss Foundation Announces U.S. Tour to Raise Awareness of MRSA in Pets 3Health News:Senior Fear Factors: What Aging Americans Fear Most 2Health News:Senior Fear Factors: What Aging Americans Fear Most 3Health News:Advance Introduces the Adgility™ XPB Battery Backpack Vacuum – the Lightest in the Industry, 2
This set offers the full range of Keeler magnifiers and telescopes....
... Featuring up to ... allows examination in the ... sections plus the option ... for corneal transillumination., ,Filters ...
... image guided surgery system offers full-featured ... design and use. It provides unparalleled ... localize critical anatomy and plan optimal ... surgeons an easy-to-use, technologically advanced approach ...
Comes complete with its own case. A unique integrated design with no need for two separate bars., ,Optical surfaces are recessed for optimum protection. Extensive prism power 1,2,3,4,6,8,10,15,20...
Medicine Products: